Company overview
Basic information
Company name
Vero alda, MB
Company code
306947272
VAT code
LT100019494717
Registered address
Kaunas, Europos pr. 34-47, LT-46370
Registration date
2024-07-09
Company age: 2 y. 2 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
Vero alda MB
Company code: 306947272
Address: Kaunas, Europos pr. 34-47, LT-46370
VAT code: LT100019494717
Download a detailed company report
Make confident decisions with all the information about Vero alda, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Vero alda, MB (company code 306947272) is an operational private small partnership registered in 2024. It belongs to the sector of national private non-financial companies and is owned under private ownership, where Lithuanian natural and legal persons hold more than 50% of authorised capital and there is no foreign investor capital. Governance is described as CEO only, and the company is classified as micro. Its registered address is Kaunas, Europos pr. 34-47, LT-46370, in Kauno m. municipality, Kauno apskr. county.
The company’s activity is registered under EVRK code G.47.73.00, retail sale of pharmaceutical products. Financially, Vero alda recorded revenue of €42.2K in 2025, up from €11.7K in 2024, and net profit of €7.1K in 2025. Profit margin was 16.9% in 2025, compared with 61.6% in 2024. At the end of 2025, total assets stood at €38.3K, equity at €14.3K and liabilities at €24.0K. Long-term assets were €22.4K and short-term assets €16.0K. The company also reported year-on-year revenue growth of 261.3% in 2025.
The company’s activity is registered under EVRK code G.47.73.00, retail sale of pharmaceutical products. Financially, Vero alda recorded revenue of €42.2K in 2025, up from €11.7K in 2024, and net profit of €7.1K in 2025. Profit margin was 16.9% in 2025, compared with 61.6% in 2024. At the end of 2025, total assets stood at €38.3K, equity at €14.3K and liabilities at €24.0K. Long-term assets were €22.4K and short-term assets €16.0K. The company also reported year-on-year revenue growth of 261.3% in 2025.